Core Scientific (CORZ) Receivables (2021 - 2025)

Core Scientific has disclosed Receivables across 5 years of filings, most recently posting $1.0 million for Q1 2025.

• In Q1 2025, Receivables fell 8.04% year-over-year to $1.0 million; the TTM figure through Mar 2025 stood at $1.0 million (down 8.04% YoY), while the FY2024 annual figure was $1.0 million, up 2.4% from the prior year.
• Receivables came in at $1.0 million for Q1 2025 at Core Scientific, down from $1.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $6.2 million in Q3 2024 to a low of $175000.0 in Q1 2023.
• Average Receivables over 5 years is $1.9 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Receivables tumbled 84.72% in 2022 and surged 532.57% in 2024.
• Over 5 years, Receivables stood at $1.7 million in 2021, then plunged by 84.72% to $257000.0 in 2022, then jumped by 289.49% to $1.0 million in 2023, then grew by 2.4% to $1.0 million in 2024, then declined by 0.68% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Receivables figures were $1.0 million in Q1 2025, $1.0 million in Q4 2024, and $6.2 million in Q3 2024.